ArticlePlastic and reconstructive surgery. Global open2025
The Efficacy of Combined Exosome (Exodew) and Microneedling Treatment for Facial Pore Reduction and Skin Texture Improvement.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Use of Microneedling With Exosomes in Dermatology: A Systematic Review.Journal of cosmetic dermatology · 2026Pooled it
- Extracellular vesicles and epigenetic aging clocks in tissue aging: an exosome-focused conceptual framework with a focus on skin.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026Review
- Persistent Hyperpigmentation Following Coretox Injection: A Review of Adverse Events Associated with Polysorbate 20.Plastic and reconstructive surgery. Global open · 2026Article
- Efficacy and Safety of a Topical Nicotinamide Adenine Dinucleotide Skinbooster for the Treatment of Melasma.Aesthetic plastic surgery · 2026Article
- Exosome-Based Therapeutics in Dermatology and Beyond: A Narrative Review.Biomedicines · 2026Review
- Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies.Cureus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Enlarged facial pores are a common aesthetic concern that worsens with age due to increased sebum production, reduced skin elasticity, and photoaging. Although microneedling is known to stimulate collagen production, the combined use of stem cell-derived exosome therapy for pore reduction has not been thoroughly investigated. Methods: A case series was conducted at a private aesthetic clinic between January and June 2024. Three patients (1 man and 2 women; 32-55 y of age; Fitzpatrick skin type IV) underwent 3 sessions of microneedling combined with topical exosome application (Exodew, Hyundae Meditech) at 4-week intervals. Standardized photographs were obtained at baseline and posttreatment. Clinical outcomes were evaluated using the Global Aesthetic Improvement Scale by 2 independent dermatologists and patient satisfaction scores at 12 and 22 weeks. Results: All patients exhibited visible reductions in pore size and improvements in skin texture and overall appearance. Global Aesthetic Improvement Scale scores ranged from 4 to 5, indicating "very much improved" outcomes. Patient satisfaction was high at both 12- and 22-week follow-ups. No adverse events were reported, and improvements were sustained through week 22. Conclusions: Microneedling combined with stem cell-derived exosome therapy seems to be a safe and effective treatment for facial pore reduction and skin texture enhancement. Larger, controlled studies are needed to confirm these preliminary results.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.